• 1. Acetyl group orientation modulates the electronic ground-state asymmetry of the special pair in purple bacterial reaction centers
  P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279
• 2. An atom-economical protocol for direct conversion of Baylis–Hillman alcohols to β-chloro aldehydes in water?
  Raktani Bikshapathi,Sai Prathima Parvathaneni,Vaidya Jayathirtha Rao Green Chem., 2017,19, 4446-4450
• 3. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
• 4. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 5. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Biphenyls and derivatives

5-(3-Hydroxymethylphenyl)-3-trifluoromethoxyphenol (CAS No. 1261919-95-2): An Overview of a Promising Compound in Medicinal Chemistry

5-(3-Hydroxymethylphenyl)-3-trifluoromethoxyphenol (CAS No. 1261919-95-2) is a novel compound that has garnered significant attention in the field of medicinal chemistry due to its unique structural features and potential therapeutic applications. This compound, characterized by its hydroxymethylphenyl and trifluoromethoxyphenol moieties, exhibits a range of biological activities that make it a valuable candidate for further research and development.

The chemical structure of 5-(3-Hydroxymethylphenyl)-3-trifluoromethoxyphenol is composed of a phenolic ring substituted with a trifluoromethoxy group at the 3-position and a hydroxymethylphenyl group at the 5-position. The presence of these functional groups imparts specific physicochemical properties to the molecule, such as enhanced lipophilicity and stability. These properties are crucial for optimizing the compound's pharmacokinetic profile and improving its bioavailability.

Recent studies have highlighted the potential of 5-(3-Hydroxymethylphenyl)-3-trifluoromethoxyphenol in various therapeutic areas. One notable application is in the treatment of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. Research has shown that this compound possesses antioxidant and anti-inflammatory properties, which are essential for mitigating the oxidative stress and inflammation associated with these conditions.

In addition to its neuroprotective effects, 5-(3-Hydroxymethylphenyl)-3-trifluoromethoxyphenol has also demonstrated promising antitumor activity. Preclinical studies have indicated that this compound can inhibit the growth of various cancer cell lines, including those derived from breast, lung, and colon cancers. The mechanism of action involves the induction of apoptosis and the suppression of cell proliferation, making it a potential candidate for further investigation in oncology.

The pharmacological profile of 5-(3-Hydroxymethylphenyl)-3-trifluoromethoxyphenol has been extensively studied using both in vitro and in vivo models. In vitro assays have shown that this compound can effectively cross the blood-brain barrier, which is a critical factor for its potential use in central nervous system (CNS) disorders. Furthermore, animal studies have demonstrated that 5-(3-Hydroxymethylphenyl)-3-trifluoromethoxyphenol exhibits low toxicity and favorable safety margins, supporting its suitability for clinical development.

The synthesis of 5-(3-Hydroxymethylphenyl)-3-trifluoromethoxyphenol involves a series of well-defined chemical reactions that can be optimized for large-scale production. Key steps include the formation of the hydroxymethylphenyl intermediate and the subsequent introduction of the trifluoromethoxy group. The robustness and reproducibility of these synthetic routes ensure consistent quality and purity of the final product.

In conclusion, 5-(3-Hydroxymethylphenyl)-3-trifluoromethoxyphenol (CAS No. 1261919-95-2) represents a promising compound with diverse biological activities and therapeutic potential. Its unique chemical structure, coupled with favorable pharmacological properties, positions it as a valuable candidate for further research and development in medicinal chemistry. Ongoing studies are expected to uncover additional applications and refine its use in various medical fields.

• 1121586-22-8((3,5-Bis(trifluoromethoxy)phenyl)methanol)
• 1261900-57-5(5-(2-Methylphenyl)-3-trifluoromethoxyphenol)
• 1261909-81-2(5-(4-Methoxy-2-methylphenyl)-3-trifluoromethoxyphenol)
• 1261919-56-5(5-(4-Methylphenyl)-3-trifluoromethoxyphenol)
• 50823-90-0(3-(Trifluoromethoxy)benzyl Alcohol)
• 1261900-66-6(5-(2,5-Dimethylphenyl)-3-trifluoromethoxyphenol)
• 1261889-01-3(5-(3-Methylphenyl)-3-trifluoromethoxyphenol)
• 1261897-70-4(5-(2-Hydroxymethylphenyl)-3-trifluoromethoxyphenol)
• 1261903-19-8(5-(2,4-Dimethylphenyl)-3-trifluoromethoxyphenol)
• 1261900-60-0(5-(4-Hydroxyphenyl)-3-trifluoromethoxyphenol)